Skip to main content
. 2013 Aug 8;81(3):763–775. doi: 10.3797/scipharm.1307-09

Fig. 2.

Fig. 2

Serum nitric oxide level in cirrhotic, hepatocellular carcinoma (HCC) patients and control group.